{
    "code": "51060989",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51060989",
    "time": "2021-11-19 05:11:19",
    "許可證字號": "衛部藥製字第060989號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/10\/12",
    "發證\/登錄日期": "110\/10\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05106098905",
    "中文品名": "&quot;霖揚&quot;氟維司群凍晶注射劑250毫克",
    "英文品名": "Fulvestrant Lyophilized Injection 250mg &quot;GBC&quot;",
    "適應症": "治療患有雌激素受體陽性的局部晚期或轉移性乳癌之停經婦女其：\r\n— 先前未接受過內分泌治療，或\r\n— 已接受輔助抗雌激素療法但疾病仍復發，或使用抗雌激素療法但疾病仍惡化。",
    "劑型": "243凍晶注射劑",
    "包裝": "250mg玻璃小瓶裝，附等支數5mL玻璃預充填針筒裝，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "新劑型",
    "監視期限": "",
    "主成分略述": "FULVESTRANT",
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "6135041295  霖揚生技製藥股份有限公司",
    "申請商地址": "苗栗縣竹南鎮頂埔里科研路50-3號4樓、50-5號4樓、50-8號3樓、50-8號4樓、50-8號5樓、50-9號5樓",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000900",
            "成分名稱": "FULVESTRANT",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單-110-11-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51060989&Seq=001&Type=9"
        },
        {
            "title": "標籤及外盒-110-11-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51060989&Seq=001&Type=8"
        }
    ]
}